Patent · US Active

Library-scale engineering of metabolic pathways

US11939571B2 · kind B2 · utility

0Cited by
1References
6Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 12, 2017
Grant dateMar 26, 2024
Priority date
Expiry dateJul 28, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC40B40/08
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Expressing guide nucleic acids (e.g., gRNA) from the same oligonucleotide that contains donor sequence permits the high efficiency, simultaneous transformation of a population of cells with both substrates. Using oligonucleotide chip array technology, one can construct thousands of oligonucleotides with customized gRNA and donor sequence in a cost effective manner. In combination, one can efficiently modify endogenous and exogenous genes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.